Ying Su

发表

Scheme 3, General synthetic strategy for analogs of ML261

Jiwen Zou, Santhi Ganji, Ian Pass, 2014 .

Figure 3, Profiling of the 21 most active VHR screening hits at 20 µM against VHR (AID-2074) & HePTP (AID-2082)

Stefan Vasile, Ying Su, Thomas D.Y. Chung, 2010 .

Figure 1, [Comparative data on (1) probe, (2) similar compound structures (establishing SAR) and (3) prior probes].

Ying Su, Thomas D.Y. Chung, Derek Stonich, 2010 .

Figure 10, SAR strategy for Scaffold I

Jiwen Zou, Santhi Ganji, Ian Pass, 2014 .

Figure 2, Probe analogs variations: 3 regions were explored by chemical synthesis: the left hand side (LHS), linker and right hand side (RHS)

Ying Su, Thomas D.Y. Chung, Derek Stonich, 2010 .

Table 5, Potencies of key screening hit scaffolds

Jiwen Zou, Santhi Ganji, Ian Pass, 2014 .

Figure 3, Flowchart Summary of Screening Results

Stefan Vasile, Eigo Suyama, Ying Su, 2011 .

Selective Bcl-2 Inhibitor Probes

Tudor I. Oprea, Bruce S. Edwards, Larry A. Sklar, 2013 .